|
Volumn 74, Issue 6, 2016, Pages 1248-1251
|
Lenalidomide for refractory chronic and subacute cutaneous lupus erythematosus: 16 patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
CORTICOSTEROID DERIVATIVE;
ETRETIN;
HYDROXYCHLOROQUINE;
LENALIDOMIDE;
METHOTREXATE;
THALIDOMIDE;
IMMUNOLOGIC FACTOR;
ADULT;
ARTHRALGIA;
ASTHENIA;
CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS;
CLINICAL ARTICLE;
DIZZINESS;
DRUG WITHDRAWAL;
FEMALE;
HEADACHE;
HUMAN;
INSOMNIA;
LETTER;
LOW DRUG DOSE;
MALE;
MIDDLE AGED;
MYALGIA;
NEUTROPENIA;
NIGHT SWEAT;
PERIPHERAL NEUROPATHY;
PRIORITY JOURNAL;
REFRACTORY CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS;
REFRACTORY SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS;
RETROSPECTIVE STUDY;
SKIN LUPUS ERYTHEMATOSUS;
SLEDAI;
SYSTEMIC LUPUS ERYTHEMATOSUS;
SYSTEMIC THERAPY;
THROMBOEMBOLISM;
TRANSIENT ISCHEMIC ATTACK;
WEIGHT REDUCTION;
ANALOGS AND DERIVATIVES;
CHRONIC DISEASE;
LUPUS ERYTHEMATOSUS, CUTANEOUS;
RETREATMENT;
ADULT;
CHRONIC DISEASE;
FEMALE;
HUMANS;
IMMUNOLOGIC FACTORS;
LUPUS ERYTHEMATOSUS, CUTANEOUS;
MALE;
MIDDLE AGED;
RETREATMENT;
THALIDOMIDE;
|
EID: 84968830533
PISSN: 01909622
EISSN: 10976787
Source Type: Journal
DOI: 10.1016/j.jaad.2016.01.054 Document Type: Article |
Times cited : (24)
|
References (5)
|